Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Shortage reports
Actual shortage:
214 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
2706 (92%)
2930
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
298 (99%)
Reversed:
0 (0%)
300
363 (11%)
100 (46%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2023-06-20 | 2023-10-06 | 195803 |
| TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2023-06-20 | 2023-10-06 | 195824 |
| TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2022-04-21 | 2022-11-12 | 159198 |
| TEVA-CLOPIDOGREL | 300MG | TABLET | Resolved | 2022-04-28 | 2022-06-17 | 159587 |
| TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2022-12-01 | 2022-12-22 | 176812 |
| TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2023-04-27 | 2023-07-05 | 190752 |
| TEVA-CLOPIDOGREL | 300MG | TABLET | Resolved | 2023-12-07 | 2024-06-24 | 212720 |
| TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2019-06-13 | 2019-07-15 | 86599 |
| TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2021-03-25 | 2021-05-13 | 136317 |
| TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2021-03-25 | 2021-04-29 | 136332 |
| TEVA-CLOXACILLIN | 125MG | GRANULES FOR SOLUTION | Resolved | 2021-01-07 | 2021-02-25 | 131063 |
| TEVA-CLOXACILLIN | 125MG | GRANULES FOR SOLUTION | Resolved | 2023-06-19 | 2023-10-03 | 195518 |
| TEVA-CLOXACILLIN | 500MG | CAPSULE | Resolved | 2023-07-13 | 2023-10-03 | 198587 |
| TEVA-CLOXACILLIN | 125MG | GRANULES FOR SOLUTION | Resolved | 2017-08-21 | 2017-09-19 | 19937 |
| TEVA-CLOXACILLIN | 250MG | CAPSULE | Resolved | 2021-10-28 | 2021-12-02 | 148424 |
| TEVA-CLOXACILLIN | 125MG | GRANULES FOR SOLUTION | Resolved | 2023-06-08 | 2023-07-05 | 194054 |
| TEVA-CLOXACILLIN | 250MG | CAPSULE | Resolved | 2022-09-07 | 2022-09-23 | 168729 |
| TEVA-CODEINE | 30MG | TABLET | Resolved | 2022-07-25 | 2022-12-22 | 165436 |
| TEVA-CODEINE | 15MG | TABLET | Resolved | 2022-07-25 | 2022-12-22 | 165444 |
| TEVA-CODEINE | 30MG | TABLET | Resolved | 2021-03-25 | 2021-06-03 | 136295 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| METHOTREXATE SODIUM INJECTION | 25MG | SOLUTION | Discontinued | 2025-04-25 | 2025-04-25 | 255818 |
| METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION | 40MG | POWDER FOR SOLUTION | Discontinued | 2021-09-23 | 2021-09-23 | 146061 |
| NOVAMOXIN | 125MG | TABLET (CHEWABLE) | Discontinued | 2019-04-11 | 2019-04-11 | 81321 |
| NOVAMOXIN | 500MG | CAPSULE | Discontinued | 2017-06-27 | 2017-06-27 | 14046 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Discontinued | 2019-04-11 | 2019-04-11 | 81316 |
| NOVAMOXIN | 250MG | CAPSULE | Discontinued | 2020-01-24 | 2020-01-24 | 104289 |
| NOVAMOXIN | 25MG | GRANULES FOR SUSPENSION | Discontinued | 2019-04-11 | 2019-04-11 | 81393 |
| NOVAMOXIN | 125MG | TABLET (CHEWABLE) | Discontinued | 2019-10-25 | 2019-10-26 | 97251 |
| NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63955 |
| NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63959 |
| NOVASEN | 650MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63964 |
| NOVO-PROFEN | 400MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64920 |
| NOVO-PROFEN | 200MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81310 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64626 |